SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001171843-19-004590
Filing Date
2019-07-15
Accepted
2019-07-15 17:15:55
Documents
4

Document Format Files

Seq Description Document Type Size
1 POS AM posam_071419.htm POS AM 241566
2 EXHIBIT 23.1 exh_231.htm EX-23.1 4463
3 GRAPHIC logo.jpg GRAPHIC 5342
4 GRAPHIC kpmg.jpg GRAPHIC 2959
  Complete submission text file 0001171843-19-004590.txt   258687
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: POS AM | Act: 33 | File No.: 333-220755 | Film No.: 19955805
SIC: 2834 Pharmaceutical Preparations